E
Twinlab Consolidated Holdings, Inc. TLCC
$0.00 $0.00-33.33% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Twinlab Consolidated Holdings, Inc. (TLCC) is a privately held nutritional supplements and wellness products company operating within the dietary supplements, vitamins, minerals, and herbal products industry. The company develops, manufactures, markets, and distributes a broad portfolio of health and wellness brands focused on sports nutrition, general wellness, herbal remedies, and specialty nutrition. Its primary revenue drivers are branded consumer products sold through retail, e‑commerce, and professional channels.

TLCC serves health-conscious consumers, athletes, and natural health practitioners, positioning itself around brand heritage, formulation expertise, and category breadth. The company traces its origins to the founding of Twinlab in 1968 and evolved into Twinlab Consolidated Holdings, Inc. following a series of restructurings and asset acquisitions in the mid‑2000s, including the consolidation of several legacy supplement brands under a single holding structure.

Business Operations

TLCC operates through multiple branded business units, generating revenue primarily from the sale of finished dietary supplement products. Its core business lines include sports nutrition, vitamins and minerals, herbal and botanical supplements, and specialty wellness products. Manufacturing is supported through a combination of internal formulation capabilities and third‑party contract manufacturers, while distribution spans brick‑and‑mortar retailers, online platforms, and practitioner channels.

The company’s portfolio includes well‑known subsidiaries and brands such as Twinlab, Metabolife, Alvita, Nature’s Herbs, Genestra Brands, and Dr. Greene’s. TLCC controls brand trademarks, product formulations, and marketing strategies, while leveraging external partners for logistics and certain manufacturing functions. Public information does not indicate material joint ventures; operations are primarily conducted through wholly owned subsidiaries.

Strategic Position & Investments

TLCC’s strategy centers on brand revitalization, portfolio diversification, and expansion in high‑growth wellness categories such as immune health, sports performance, and natural remedies. The company has historically pursued growth through the acquisition of distressed or under‑leveraged supplement brands, integrating them into its centralized operating platform to improve scale and distribution efficiency.

Notable past acquisitions include Metabolife, Alvita, and Nature’s Herbs, which expanded TLCC’s reach across mass‑market and natural product channels. The company has also invested in formulation updates and compliance infrastructure to align products with evolving regulatory standards. Public sources indicate ongoing involvement in nutraceutical innovation, though specific emerging technology investments beyond traditional supplement categories are not fully disclosed. Data inconclusive based on available public sources regarding recent acquisitions or capital investments.

Geographic Footprint

Twinlab Consolidated Holdings, Inc. is headquartered in the United States, with corporate offices historically reported in New York. Its primary operational focus is North America, where the majority of sales and distribution activities occur.

Internationally, TLCC products are distributed in select Europe, Asia, and Latin America markets through third‑party distributors and licensing arrangements rather than direct subsidiaries. While the company maintains global brand recognition, publicly available data suggests its international footprint is limited compared to larger multinational supplement companies.

Leadership & Governance

TLCC operates as a privately held company with governance overseen by its executive leadership team. The company’s leadership philosophy emphasizes brand stewardship, regulatory compliance, and long‑term portfolio value creation. Founder involvement is historical, with governance transitioning to professional management following restructuring in the 2000s.

Key executives publicly associated with the company include:

  • Rhea Chlebowski – Chief Executive Officer
  • David Chlebowski – Executive Chairman
  • Robert Hoffman – Senior Vice President, Sales
  • Ken Wolf – Chief Financial Officer

Executive roles and titles are derived from public business filings and industry publications; however, some leadership details may vary across sources. Data inconclusive based on available public sources regarding recent changes in executive appointments.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $175.97
B
AAPL NASDAQ $247.55
B
MSFT NASDAQ $384.04
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $120.02
B
Top Financial Stocks
See All »
B
B
JPM NYSE $287.42
B
V NYSE $299.35
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $53.95
Top Health Care Stocks
See All »
B
LLY NYSE $916.01
B
JNJ NYSE $236.63
B
AMGN NASDAQ $347.92
Top Real Estate Stocks
See All »
B
PLD NYSE $129.50